Utility of the Brixia CXR score, C-Reactive Protein and Absolute Neutrophil Count in Predicting the Need for Invasive Mechanical Ventilation, Length of Hospital Stay, and Mortality in Moderate to Severe COVID-19 Patients
IF 0.2
Q4 ANESTHESIOLOGY
V. Shanbhag, Souvik Chaudhuri, N. Arjun, A. Pandey, P. Vishwas, Megha Sharma
求助PDF
{"title":"Utility of the Brixia CXR score, C-Reactive Protein and Absolute Neutrophil Count in Predicting the Need for Invasive Mechanical Ventilation, Length of Hospital Stay, and Mortality in Moderate to Severe COVID-19 Patients","authors":"V. Shanbhag, Souvik Chaudhuri, N. Arjun, A. Pandey, P. Vishwas, Megha Sharma","doi":"10.4038/slja.v31i1.8905","DOIUrl":null,"url":null,"abstract":"Background: The Brixia Chest X-ray (CXR) score, C-reactive protein (CRP), and the absolute neutrophil count (ANC) have been useful to predict outcomes in Coronavirus disease 2019 (COVID-19 patients). We studied the utility of the Brixia CXR score, CRP, and ANC in predicting the outcomes in terms of the need for invasive mechanical ventilation, length of stay, and mortality in moderate-severe COVID-19 patients. Material(s) and Method(s): This was a single-centre, retrospective, study on 122 COVID-19 patients. Brixia CXR score, CRP, and ANC on admission to the hospital and the fifth day of hospital stay were noted along with the need for invasive mechanical ventilation (IMV), prolonged length of stay (LOS) >= 14 days, and mortality. Result(s): 122 patients were included for analysis. The median and interquartile range (IQR) for baseline CRP was 81.50 (39-151) mg/L and 11.0 (4-30) mg/L (p < 0.001) on the fifth day. The median and IQR for baseline Brixia score was 10.0 (7-13), and on the fifth day was 7 (4-11) (p <0.001). The receiver operating characteristic curve (ROC) showed that the baseline CRP >= 52.5mg/L predicted both the need for IMV, with an area under the curve (AUC) of 0.628, and prolonged LOS with an AUC of 0.608. The ROC curve depicted that the baseline ANC >8500/muL predicted IMV requirement with an AUC of 0.657. The fifth day CRP >= 32 mg/L, ANC >= 11,000/ muL and Brixia CXR score >= 7 predicted a higher mortality in hospitalized patients. Conclusion(s): Baseline CRP (> 52.5mg/L) predicts the need for IMV and a prolonged LOS, but not mortality. Baseline ANC (> 8500/muL) predicted the need for IMV. CRP, Brixia CXR score, and ANC on the fifth day were not useful to predict LOS or mortality, though there was a significant reduction in CRP and Brixia CXR score on the fifth day compared to baseline after treatment. The fifth day CRP >= 32 mg/L, ANC >= 11,000/ muL and Brixia CXR score >= 7 predicted a higher mortality.Copyright © 2023, College of Anaesthesiologists of Sri Lanka. All rights reserved.","PeriodicalId":41531,"journal":{"name":"Sri Lankan Journal of Anaesthesiology","volume":" ","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2023-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sri Lankan Journal of Anaesthesiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4038/slja.v31i1.8905","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0
引用
批量引用
Abstract
Background: The Brixia Chest X-ray (CXR) score, C-reactive protein (CRP), and the absolute neutrophil count (ANC) have been useful to predict outcomes in Coronavirus disease 2019 (COVID-19 patients). We studied the utility of the Brixia CXR score, CRP, and ANC in predicting the outcomes in terms of the need for invasive mechanical ventilation, length of stay, and mortality in moderate-severe COVID-19 patients. Material(s) and Method(s): This was a single-centre, retrospective, study on 122 COVID-19 patients. Brixia CXR score, CRP, and ANC on admission to the hospital and the fifth day of hospital stay were noted along with the need for invasive mechanical ventilation (IMV), prolonged length of stay (LOS) >= 14 days, and mortality. Result(s): 122 patients were included for analysis. The median and interquartile range (IQR) for baseline CRP was 81.50 (39-151) mg/L and 11.0 (4-30) mg/L (p < 0.001) on the fifth day. The median and IQR for baseline Brixia score was 10.0 (7-13), and on the fifth day was 7 (4-11) (p <0.001). The receiver operating characteristic curve (ROC) showed that the baseline CRP >= 52.5mg/L predicted both the need for IMV, with an area under the curve (AUC) of 0.628, and prolonged LOS with an AUC of 0.608. The ROC curve depicted that the baseline ANC >8500/muL predicted IMV requirement with an AUC of 0.657. The fifth day CRP >= 32 mg/L, ANC >= 11,000/ muL and Brixia CXR score >= 7 predicted a higher mortality in hospitalized patients. Conclusion(s): Baseline CRP (> 52.5mg/L) predicts the need for IMV and a prolonged LOS, but not mortality. Baseline ANC (> 8500/muL) predicted the need for IMV. CRP, Brixia CXR score, and ANC on the fifth day were not useful to predict LOS or mortality, though there was a significant reduction in CRP and Brixia CXR score on the fifth day compared to baseline after treatment. The fifth day CRP >= 32 mg/L, ANC >= 11,000/ muL and Brixia CXR score >= 7 predicted a higher mortality.Copyright © 2023, College of Anaesthesiologists of Sri Lanka. All rights reserved.
Brixia CXR评分、c反应蛋白和绝对中性粒细胞计数在预测中重度COVID-19患者有创机械通气需求、住院时间和死亡率中的应用
背景:Brixia胸片(CXR)评分、c反应蛋白(CRP)和绝对中性粒细胞计数(ANC)可用于预测2019冠状病毒病(COVID-19患者)的预后。我们研究了Brixia CXR评分、CRP和ANC在预测中重度COVID-19患者有创机械通气需求、住院时间和死亡率方面的应用。材料和方法:这是一项针对122例COVID-19患者的单中心回顾性研究。记录患者入院时和住院第5天的bricia CXR评分、CRP和ANC,以及是否需要进行有创机械通气(IMV)、延长住院时间(LOS) >= 14天和死亡率。结果:122例患者纳入分析。第5天,基线CRP的中位数和四分位数范围(IQR)分别为81.50 (39-151)mg/L和11.0 (4-30)mg/L (p < 0.001)。基线Brixia评分的中位数和IQR为10.0(7-13),第5天为7 (4-11)(p = 52.5mg/L预测IMV需求,曲线下面积(AUC)为0.628,延长LOS的AUC为0.608)。ROC曲线显示,基线ANC bbb8500 /muL预测IMV需求,AUC为0.657。第5天CRP >= 32 mg/L, ANC >= 11000 /L, Brixia CXR评分>= 7预示住院患者的死亡率较高。结论:基线CRP (> 52.5mg/L)预测IMV的需要和延长的LOS,但不能预测死亡率。基线ANC (bbb8500 /muL)预测了IMV的需求。治疗后第5天的CRP、Brixia CXR评分和ANC对预测LOS或死亡率没有帮助,尽管第5天的CRP和Brixia CXR评分与基线相比有显著降低。第5天CRP >= 32 mg/L, ANC >= 11000 /L, Brixia CXR评分>= 7预示着较高的死亡率。版权所有©2023,斯里兰卡麻醉师学院。版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。